Coherus Oncology, Inc. Income (Loss) from Continuing Operations, Per Basic Share
Coherus Oncology, Inc. (CHRS) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.22 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2026-08-05
- Coherus Oncology, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2026-06-30 was -$0.22.
- Coherus Oncology, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2026-03-31 was -$0.27.
- Coherus Oncology, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2025-09-30 was -$0.38.
- Coherus Oncology, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2025-06-30 was -$0.39.
- Coherus Oncology, Inc. income (loss) from continuing operations, per basic share for fiscal 2025 was -$1.56.
- Coherus Oncology, Inc. income (loss) from continuing operations, per basic share for fiscal 2024 was -$1.88.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.22 10-Q · filed 2026-08-05 | -$0.48 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | -$0.27 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | -$1.56 10-K · filed 2026-03-09 | |||
| 2025-09-30 | -$0.38 10-Q · filed 2025-11-06 | -$1.18 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | -$0.39 10-Q · filed 2026-08-05 | -$0.80 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | -$0.41 10-Q · filed 2026-05-11 | |||
| 2024-12-31 | -$1.88 10-K · filed 2026-03-09 | |||
| 2024-09-30 | -$0.41 10-Q · filed 2025-11-06 | -$1.48 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$0.48 10-Q · filed 2025-08-07 | -$1.08 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$0.60 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$2.36 8-K · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |